| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |